An International Encapsulating Peritoneal Sclerosis Registry and DNA Bank: Why We Need One Now

Weber J. , Mettang T. , Mayer-Wehrstein R. , Kuhlmann U. [Continuous ambulatory peritoneal dialysis. Patient and method survival rate, peritonitis incidence and dialysis efficacy over 10 years]. Dtsch Med Wochenschr 1991; 116: 641–8.

Rigby R.J. , Hawley C.M. Sclerosing peritonitis: the experience in Australia. Nephrol Dial Transplant 1998; 13: 154–9.

Kawanishi H. , Moriishi M. Epidemiology of encapsulating peritoneal sclerosis in Japan. Perit Dial Int 2005; 25(Suppl 4): S14–18.

Kawanishi H. , Kawaguchi Y. , Fukui H. , Hara S. , Imada A. , Kubo H. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am J Kidney Dis 2004; 44: 729–37.

Summers A.M. , Clancy M.J. , Syed F. , Harwood N. , Brenchley P.E. , Augustine T. Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure. Kidney Int 2005; 68: 2381–8.

Brogan I.J. , Khan N. , Isaac K. , Hutchinson J.A. , Pravica V. , Hutchinson I.V. Novel polymorphisms in the promoter and 5’ UTR regions of the human vascular endothelial growth factor gene. Hum Immunol 1999; 60: 1245–9.

Cambien F. , Ricard S. , Troesch A. , Mallet C. , Generenaz L. , Evans A. Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension 1996; 28: 881–7.

Renner W. , Kotschan S. , Hoffmann C. , Obermayer-Pietsch B. , Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 2000; 37: 443–8.

Watson C.J. , Webb N.J. , Bottomley M.J. , Brenchley P.E. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000; 12: 1232–5.

Gillerot G. , Goffin E. , Michel C. , Evenepoel P. , Biesen W.V. , Tintillier M. Genetic and clinical factors influence the baseline permeability of the peritoneal membrane. Kidney Int 2005; 67: 2477–87.

Numata M. , Nakayama M. , Hosoya T. , Hoff C.M. , Holmes C.J. , Schalling M. Possible pathologic involvement of receptor for advanced glycation end products (RAGE) for development of encapsulating peritoneal sclerosis in Japanese CAPD patients. Clin Nephrol 2004; 62: 455–60.

Hurst H. , Summers A. , Hutchison A.J. CT scanning in the detection of early peritoneal sclerosis. Poster presentation at EuroPD Prague, 15–18 October 2005.

Ho-dac-Pannekeet M.M. , Hiralall J.K. , Struijk D.G. , Krediet R.T. Markers of peritoneal mesothelial cells during treatment with peritoneal dialysis. Adv Perit Dial 1997; 13: 17–22.

Pecoits-Filho R. , Araujo M.R. , Lindholm B. , Stenvinkel P. , Abensur H. , Romao J.E. Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 2002; 17: 1480–6.

Masunaga Y. , Muto S. , Asakura S. , Akimoto T. , Homma S. , Kusano E. Ascites from patients with encapsulating peritoneal sclerosis augments NIH/3T3 fibroblast proliferation. Ther Apher Dial 2003; 7: 486–93.

Afthentopoulos I.E. , Passadakis P. , Oreopoulos D.G. , Bargman J. Sclerosing peritonitis in continuous ambulatory peritoneal dialysis patients: one center's experience and review of the literature. Adv Ren Replace Ther 1998; 5: 157–67.

Bhandari S. , Wilkinson A. , Sellars L. Sclerosing peritonitis: value of immunosuppression prior to surgery. Nephrol Dial Transplant 1994; 9: 436–7.

Genereau T. , Bellin M.F. , Wechsler B. , Le T.H. , Bellanger J. , Grellet J. Demonstration of efficacy of combining corticosteroids and colchicine in two patients with idiopathic sclerosing mesenteritis. Dig Dis Sci 1996; 41: 684–8.

Mori Y. , Matsuo S. , Sutoh H. , Toriyama T. , Kawahara H. , Hotta N. A case of a dialysis patient with sclerosing peritonitis successfully treated with corticosteroid therapy alone. Am J Kidney Dis 1997; 30: 275–8.

Bowers V.D. , Ackermann J.R. , Richardson W. , Carey L.C. Sclerosing peritonitis. Clin Transplant 1994; 8: 369–72.

Hendriks P.M. , Ho-dac-Pannekeet M.M. , van Gulik T.M. , Struijk D.G. , Phoa S.S. , Sie L. Peritoneal sclerosis in chronic peritoneal dialysis patients: analysis of clinical presentation, risk factors, and peritoneal transport kinetics. Perit Dial Int 1997; 17: 136–43.

Kawaguchi Y. , Kawanishi H. , Mujais S. , Topley N. , Oreopoulos D.G. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int 2000; 20(Suppl 4): S43–55.

Lee H.Y. , Kim B.S. , Choi H.Y. , Park H.C. , Kang S.W. , Choi K.H. Sclerosing encapsulating peritonitis as a complication of long-term continuous ambulatory peritoneal dialysis in Korea. Nephrology (Carlton) 2003; 8(Suppl): S33–9.

Kawanishi H. , Watanabe H. , Moriishi M. , Tsuchiya S. Successful surgical management of encapsulating peritoneal sclerosis. Perit Dial Int 2005; 25(Suppl 4): S39–47.